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The immunologic status of 25 patients with dis eminated coccidioidomycosis was evalu-
ated by serum anticoccidioidin complement-fixing antibody levels, coccidioidin skin tests, 
and dinitrochlorobenzene (DNCB) sensitization. In the 10 patients who had disseminated 
disease and a complement-fixing titer of 1:32 or less. responses to D CB were similar to those 
of 20 controls. In the 15 patients with dis eminated disease and a complement-fixing titer of 
1:64 or more , responses to D CB were statistically significantly diminished compared to 
controls (p = 0.002). Since the complement-fixing titer is as ociated with extent of 
dissemination, these results signify a relationship between diminis hed DNCB responses and 
extensive dissemination. Of the several hypotheses which might explain this relationship, we 
find the most attractive is that of a nonspecific deficiency of cell-mediated immunity 
developing secondarily to extensive disseminated disease. 
Depression of cell-mediated immune (CMI) re-
sponses, either specific and/or nonspecific, has 
been observed in patients with disseminated gran-
ulomatous infections including lepromatous lep-
rosy [1], and several systemic mycoses such as 
coccidioidomycosis [2-4]. South American blas-
tomycosis [5,6] and cryptococcosis [7,8]. It is not 
known whether this depression is a predisposing 
cause of or a result of dissemination. 
This problem of cause or result may be amenable 
to solution particularly by the study of dis-
seminated coccidioidomycosis (DC) because this 
disorder is not rare, variability in extent is fre -
quently encountered, and this variability has a 
well-accepted marker, the anticoccidioidin com-
plement-fixing antibody (CF ) titer [2,9]. The pur-
pose of this paper is to present evidence that a 
nonspecific impairment of CMI is present in some 
patients with DC and that this nonspecific defi-
ciency of CMI is associated with extensive dissemi -
nation, but not with limited dissemination. 
MATERIALS AND METHODS 
The subjects of th is study were patients either from the 
Los Angeles County/University of Southern California 
Medical Center or from the private practice of one of us 
(H.E.). They numbered twenty-five, 22 men and 3 
women . The median age was 32 years and age ranged 
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from 15 to 54 years. Ethnically classified. there were 9 
Caucasian Americans, Mexican-Americans, 4 Negro 
American , 2 Chinese. 1 Filipino, and 1 avajo . Twenty-
three patients received amphotericin-B. during the 
study. although only 2 patients had received more than 1 
gm of amphotericin-B when studied . The 20 controls for 
DNCB sensitization were medical students, medical 
center employees, and dermatology clinic patients with 
sk in lesions considered to have no immunologic signifi-
cance such as seborrheic keratoses , nevi , and post-
traumatic scars ; they included 13 men and 7 women with 
a median age of 28 years and, ethnically classified , 
consisted of 12 Caucasian Americans and 8 Mexican-
Americans. 
The diagnosis of DC was based on the demonstration of 
Coccidioides immitis in extrapulmonary tissue or, in the 
ca.'e of central nervous system involvement. on the 
presence of specific CF antibody in the cerebrospinal 
fluid . 
Serum and cerebrospinal fluid CF titers were mea -
sured by methods previously described [2]. For this study 
the patient's serum titer was the highest dilution giving 
a 3 or 4+ reaction during the time of the attempted 
DNCB sensitization. Cutaneous delayed reactivity to 
coccidioidin was elicited by intradermal admini tration 
of 0.1 ml of 1:100 dilution of commercial coccidioidin, 
USP. The test respon e was interpreted as positive if 
induration of at least 5 mm was present at 48 hr. 
Sensitization to the epicutaneous application of 2,4-
dinitro- l-chlorobenzene (DNCB) was attempted by a 
modification of the method of Waldorf et al [10]. A 2-mg 
sensitizing dose applied to the upper back was followed in 
3 weeks by challenge doses of 0.1, 0.05, and 0.025 mg 
which were read 3 days later. Primary flare at the 
sensitization sit,e and the response to challenge were 
interpreted as positive if induration (+ + ), vesicles 
(+ + l. or bullae (+ + + +) were elicited; erythema alone 
(+) was interpreted as negative . 
The chi square test was chosen to determine statistical 
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significance, using Fisher's exact method. A p value of 
0.05 or less was selected as significant. 
RESULTS 
By inspection of the data, detailed in Table I, it 
is evident that patients with a CF titer of 1:32 or 
less, hereafter referred to as the low titer group, 
have a greater positive response rate to the coccidi-
oidin skin test and a greater sensitization rate to 
DNCB than do patients with a CF titer of 1:64 or 
greater, hereafter referred to as the high titer 
group . 
The positive response rates for patients and 
controls are summarized in Table II. The DNCB 
response rates of the group of patients with low CF 
titers are similar to those of the controls, whereas 
the reactions of the group of patients with a high 
CF titer are diminished. 
A statistical analysis of the D CB responses was 
performed comparing both the low CF titer group 
and the high CF titer group with the controls. The 
low CF titer group was not statistically different 
from the controls when primary flare or challenge 
dose responses were studied. The high CF titer 
group was statistically different (p < 0.002) when 
primary flare and challenge dose responses were 
analyzed. When the data were corrected for the 
number of specificities tested , the differences were 
still statistically significant (p < 0.05). 
A statistical comparison of DNCB responsi vity, 
coccidioidin responsivity, and high/low CF titers 
was made in the 25 DC patients. There was a 
strong concordance between high/low CF titer and 
D CB responsivity (p = 0.016), which is statisti-
cally significant when corrected by multiplying by 
3. There was a weaker concordance between high/ 
TABLE 1. Results of testing in patients with disseminated coccidioidomycosis 
Coccidioidin 
Patient Com plement.fixing skin test 
number antibody titer react ion 
1 1/1024 Neg 
2 1/512 Neg 
3 1/256 Neg 
4 1/ 256 Neg 
5 1/256 Pos 
6 1/ 128 Pos 
7 1/128 Pos 
8 1/ 128 Neg 
9 1/128 Pos 
10 1/64 Pos 
11 1/64 Pos 
12 1/64 Neg 
13 1/64 Pos 
14 1/64 Neg 
15 1/64 eg 
16 1/32 Pos 
17 1/32 Pos 
18 1/32 Pos 
19 1/ 32 Neg 
20 1/32 Pos 
21 1/16 Neg 
22 1/16 Pos 
23 1/8 Pos 
24 1/8 Pos 
25 1/8 Pos 
Primary 
flare ' 
++ 
J.++ 
++ 
J.+ 
++ 
++ 
DNCB responses 
Challen~e dose 
0.1 mg 0.05mg- 0.025 mg 
+~ 
J.+ 
+ 
T~ 
+++ +T-r 
J.+ ++ 
++ "'"+ 
+++ ++ 
++ ++ 
++ ++ 
TABLE II . A sum mary of responses to coccidioidin skin tests and DNCB 
Positive Positive DNCB responses 
Group coccidioidin Challen~e do e skin Primary 
test flare 0.1 mg 0.05 m~ 0.025 mg 
All patients (25) 60% 28 0/c 46% 29 % 13"'c 
Patients with CF titer of 1:64 or more (15) 47 0/c 0 33% 7"k 0 
Patients with CF titer of 1:32 or less (0) 80% 70% 78 % 67 % 33e; 
Controls 50% 85 % 60 % 55", 
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low CF titer and coccidioidin skin test positivity (p 
= 0.21) , and a similarly weak concordance between 
DNCB and coccidioidin skin test responsivity (p = 
0.22). 
DISCUSSION 
Using D CB sensitization as a measure , a 
deficiency of CMI has been demonstrated in DC 
patients with high anticoccidioidin CF antibody 
titers . Assuming that there is no cross -reactivity 
between D CB and antigens of C. immitis we 
conclude that the demonstrated deficiency is non-
~pecific, an assumption and conclusion similar to 
those made by others who have used DNCB 
[1,5,lOJ. DC patients with low CF titers responded 
normally. A nonspecific deficiency of CMI in DC 
patients has been reported previously; Fiese [3J 
noted diminished responses to tuberculin and 
Catanzaro et al [4] reported unresponsiveness to a 
battery of intradermal antigens as well as reduced 
in vitro lymphocyte transformation by phytohe-
magglutinin (PHA) in 4 of 8 patients with DC, but 
neither mentioned a correlation with CF titer. 
Because DNCB responses in DC are diminished 
in patients with high CF titers but are normal in 
patients with low CF titers, DNCB unresponsive-
ness is not apt to reflect dissemination per se. 
Because D CB unresponsiveness is associated 
with a high CF titer, and because a high CF titer is 
associated with extensive dissemination [2,9] we 
conclude that DNCB unresponsiveness is associ-
ated with extensive dissemination. 
What i!1 the significance of this association 
between DNCB unresponsiveness and extensive 
dissemination? It could signify (a) a chance rela-
tionship, (b) a causal relationship , i.e., a preexist -
ing defect of nonspecific CMI is a predisposing 
cause for dissemination , or (c) a secondary rela -
tionship, i.e., the deficit of CMI is secondary to 
extensive dissemination. 
A chance relationship between DNCB unrespon-
siveness and extensive DC cannot be excluded 
absolutely, but statistically is unlikely . A p value 
of 0.016 was obtained when comparing highllow CF 
titers with D CB responsivity and a p value ofless 
than 0.002 was obtained when comparing the 
DNCB responses of high-titer patients with normal 
controls . 
A causal relationship is not a good explanation, 
because it is difficult to interpret the failure of DC 
patients with low CF titers to manifest DNCB 
unresponsiveness if a nonspecific deficit of CMI is 
regarded as an usual condition for dissemination . 
(However, in unusual circumstances, such as renal 
transplantation with immunosuppression [11], 
nonspecific deficits of CMI can predispose to 
dissemination.) 
A secondary relationship is a satisfactory expla-
nation for the association of DNCB unresponsive-
ness and extensive dissemination , because the 
relationship can be accounted for by an antigen 
excess state, as can the anergy associated with 
some other infections in humans [12- 15] . This 
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secondary relationship is supported by the report 
of Cantanzaro et al [4] who observed in 2 patients 
with DC a return of PHA-induced lymphocyte 
transformation to normal following clinical im-
provement. 
Other explanations of the relationship of DNCB 
unresponsiveness and extensive dissemination can 
be constructed. A universally distributed nonspe-
cific deficit of CM!, either predisposing or second-
ary , but not perceptible by DNCB sensitization, 
we view as unlikely because of the report of 
Catalona et al [16] which provides eviden~e that 
the results obtained with other methods will be 
similar to those obtained with DNCB. Two types of 
DC can be postulated, one with a predisposing 
nonspecific deficit of CMI characterized by exten-
sive dissemination and the other with no deficit 
characterized by limited dissemination; a coccidi-
oidin-positive skin test response rate of 47% in 
patients with high CF titers is inconsistent with 
this idea . 
The separation of patients with disseminated 
disease into two groups, one with CF titers of 1:32 
or less and the other with CF titer of 1:64 and 
above, was done as a result of inspection of our 
data where differences in responses to DNCB are 
evident. The subsequent designation of these two 
groups as "low" or " high" titer is for the sake of 
brevity and should not be confused with the use of 
"high titer" as synonymous with " in the dis-
seminated range or 1:32 or greater ." (Our labora-
tory uses standards established by Smith et al [2] 
and a titer of 1:32 or more is considered to be "in 
the disseminated range . ") 
It is surprising that the differences in DNCB 
responsiveness are so sharp between patients with 
CF titers of 1: 32 and 1 :64, considering that there is 
only a one-tube separation between the two groups. 
We think that this is in part a chance finding and 
predict that further studies will show "smudging" 
at this boundary. 
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